GSK Articles
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
FDA panel backs safety of B-MS/AZ' Onglyza
2 April 2009
Stock Commentary - New York week to March 30, 2009
2 April 2009
GSK setback for malaria vacc in Africa
2 April 2009
Valeant appoints GSK's Steve Stefano to its board
2 April 2009
GSK submits final data to FDA from Cervarix BLA
2 April 2009
GSK/Shire Vyvanse deal fuels speculation
1 April 2009
GSK's Synflorix approved in Europe
1 April 2009
Ligand gets $500K under GSK accord
31 March 2009
GSK and Sanofi vying for Shantha?
31 March 2009
Drug pricing heats up BUPA health debate
31 March 2009
GSK news includes Allergan buy rumors
30 March 2009
GSK appeals UK's NICE refusal for Tyverb
30 March 2009
US patent ruling "potential setback for UK pharma"
30 March 2009
$28 Million Paxil settlement proposed
30 March 2009
ECJ on parallel trade: no clear ruling
30 March 2009
GSK forms amyloidosis partnership with Univ
30 March 2009
EFPIA response to Dutch customs' Rx drug grab
30 March 2009
Wales' HPV vacc catch up campaign accelerated
30 March 2009
Flamel gets additional $4M GSK milestone
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
Stiefel Labs viewing a sale of itself? WSJ
30 March 2009
GSK sells part of its Quest sake for $256M
30 March 2009
GSK offers payout to end French strike
23 March 2009
Japan stock market week to March 16, 2009
23 March 2009
NDA acceptance triggers $23M fee to XenoPort
23 March 2009
GSK India more than doubles profit in 4th qtr
23 March 2009
Prasco to distribute GSK generics
16 March 2009
Azilect helps "double 2nd-line MAO-Bs in PD"
16 March 2009
WTO dispute over generic drug seizures
16 March 2009
Regulus raises $20M
16 March 2009
GSK reduces CEO remuneration package
16 March 2009
GSK submits EMEA MAA for pazopanib in RCC
9 March 2009
Stock Commentary - Europe - week to mar 2, 2009
9 March 2009
NICE chairman and GSK VP to clash at BUPA conf
9 March 2009
China
9 March 2009
FDA says TV ad for GSK
9 March 2009
New guidelines to help boost use of 5-ARIs
9 March 2009
Agility and innovation, at Economist
9 March 2009
Four Novartis drugs and B-MS
9 March 2009
XenoPort swings into loss of $62.5M in 2008
2 March 2009
Japan stock market week to Feb 23, 2009
2 March 2009
GSK's CEO warns SE Asia on fake drugs
2 March 2009
Biota's six-month profit jumps 31% on GSK deal
2 March 2009
Llamas way forward for antibody drugs
23 February 2009
10 years of drugmaker action against lymphatic filiarisis
23 February 2009
Synta gets $10M milestone from GSK under elesclomol accord
23 February 2009
Novo Nordisk promotes Andy Ajello to VP, national diabetes sales
23 February 2009
Stock Commentary - Europe - week to Feb 16, 2009
23 February 2009
Drug identified to treat opioid addiction
23 February 2009
GSK doses first patient in Ph III Syncria trial
23 February 2009
GSK and Theravance report strong ICS results
23 February 2009
Drugmakers remain attractive employers in Belgium
23 February 2009
Deeper loss for Vertex on high costs, low sales
23 February 2009
Ligand swings to loss on merger and legal fees
23 February 2009
Spain withdraws batch of Gardasil after two adverse events
16 February 2009
UPDATE: Dutch NGO's CT claims rebutted by GSK and AZ
16 February 2009
Stock Commentary - Europe - week to Feb 9, 2009
16 February 2009
US FDA clears Teva's generic Imitrex
16 February 2009
Dutch NGO's CT claims rebutted by GSK
16 February 2009
India's Piramal denies it is in takeover talks
16 February 2009
Liraglutide combos see greater HbA1c drop
16 February 2009
Lilly promotes Enrique Conterno to president of Lilly USA to replace Deirdre Connelly
9 February 2009
BLA submitted for GSK and Genmab's Arzerra
9 February 2009
Synta/GSK
9 February 2009
Lexapro and Zoloft are "best" antidepressants
9 February 2009
GSK to record $400M 4th-qtr legal charge
9 February 2009
UK gov orders 10.6M doses of Relenza
9 February 2009
EC approves GSK's OTC orlistat product alli
26 January 2009
Retail drug sales in year to November 2008
26 January 2009
Japan stock market week to Jan 19, 2009
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Taisho and GSK to develop orlistat in Japan
26 January 2009
H3N2 flu outbreak hits Europe: low vacc levels blamed
19 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
19 January 2009
GSK signs L86M R&D deal with Biotica
19 January 2009
GSK/XenoPort resubmit NDA in RLS
19 January 2009
Galapagos gets $2.7M as GSK expands alliance
15 January 2009
FDA 2008 NCE appros exceed expectations
12 January 2009
PDCO meeting sees good news for J&J but a mix for GSK and AZ; Janssen pulls Invega app
12 January 2009
GSK initiates large-scale darapladib CHD trial
12 January 2009
Ligand licenses drug to GSK for $163M
12 January 2009
GSK licenses PER.C6 to research a protein
12 January 2009
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
